Phenethyl cinnamate

Skin irritation / corrosion

Administrative data

Endpoint:

skin irritation: in vitro / ex vivo

Type of information:

experimental study

Adequacy of study:

key study

Study period:

08.08.2016-15.08.2016

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2017

Report date:

2017

Materials and methods

Test guideline

Test guideline 1

Qualifier:

according to guideline

Guideline:

OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)

Version / remarks:

adopted July 28,
2015

Deviations:

yes

Remarks:

yes Instead of the MatTek EPI-200-SIT Kit, the MatTek EPI-200-PHO Test kit was used for the experimental performance. This Deviation had no influence on the outcome of the study (identical test kits with only the cell culture medium being different).

Test guideline 2

Qualifier:

according to guideline

Guideline:

EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)

Version / remarks:

1st ATP 2009

Deviations:

not specified

Test guideline 3

Qualifier:

according to guideline

Guideline:

other: UN GHS

Version / remarks:

6th revision, 2015

Deviations:

not specified

GLP compliance:

yes (incl. QA statement)

Remarks:

Hess. Ministerium fuer Umwelt, Klimaschutz, Landwirtschaft und Verbraucherschutz, Wiesbaden

Test material

Test material information

Constituent 1

Reference substance name:

Phenethyl cinnamate

EC Number:

203-120-3

EC Name:

Phenethyl cinnamate

Cas Number:

103-53-7

Molecular formula:

C17H16O2

IUPAC Name:

phenethyl cinnamate

In vitro test system

Test system:

human skin model

Source species:

human

Cell type:

non-transformed keratinocytes

Cell source:

other: human-derived epidermal keratinocytes

Source strain:

other: not applicable

Details on test system:

- Source: MatTek Corporation (82105 Bratislava, Slovakia).
- The EpiDerm™ tissue: normal, human-derived epidermal keratinocytes which have been cultured to form a multilayered, highly differentiated model of the human epidermis.
- Surface: 0.6 cm.
- Shipment: with cool packs on medium-supplemented agarose gels.
- Pre-incubation: 60 minutes in the incubator (37 ± 1.5 °C, 5 ± 1% CO2, 95 ± 5% RH) in the upper wells. Then transferred from upper wells into the lower wells for about 20.5 hours (37 ± 1.5 °C, 5 ± 1% CO2, 95 ± 5% RH).

Control samples:

yes, concurrent negative control

yes, concurrent positive control

Amount/concentration applied:

25 mg (~ 39 mg/cm2 according to guideline)

Duration of treatment / exposure:

60 minutes

Duration of post-treatment incubation (if applicable):

23.5h at 37+/-1.5°C, 5+/-1% CO2, 95+/-5% RH

Number of replicates:

3

Test system

Details on study design:

Details of the test procedure used:
- EpiDerm™ tissue of human-derived epidermal keratinocytes was used (Epi-200- PHO Kit, Lot No.:23349)
- Conditions of exposure: 37 ± 1.5 °C, 5 ± 0.5% CO2, 95%
- Washing: inserts gently rinsed with DPBS at least 15 times
- Number of tissue replicates used per test chemical and controls: 3
- MTT assay: incubation with 0.3 mL of MTT solution for 3 hours at 37 ± 1 °C, 5 ± 0.5% CO2)

Data evaluation:
The following was calculated: The mean OD of the three negative control tissues was calculated after blank correction. This value corresponds to 100% tissue viability in the current test. For each individual tissue treated with the test item or the positive control the individual relative tissue viability is calculated according to the following formula: Relative viability(%) = (mean OD test item / positive control / mean OD negative control) x 100. For the test item and the positive control the mean relative viability ± rel. standard deviation of the three individual tissues was calculated.

Description of evaluation criteria:
For the current test, an irritation potential of the test item of H315, GHS Cat 2 according to UN GHS (published 2003, last (6th) revision 2015) is recommended if the mean relative tissue viability of three individual tissues is reduced ≤ 50% of the negative control.

Historical data:
- Historical data positive control: Mean Viability: 4.64%; Rel. Standard Deviation: 11.2%; Range of Viabilities: 4.00% - 5.90%; Mean Absorption: 0.0803; Rel. Standard Deviation: 12.6%; Range of Absorbance: 0.066-0.097
- Historical data negative control: Mean Absorption: 1.74; Rel. Standard Deviation: 8.68%; Range of Absorbance: 1.48-1.98

Acceptability of the Assay:
The results are acceptable if (1) tissue viability is meeting the acceptance criterion, i.e. if the mean OD570 of the negative control tissues is ≥ 0.8 and ≤ 2.8 (negative control). If (2) the relative tissue viability of the positive control is ≤ 20% (positive control). If (3) the SD of 3 identical replicates is < 18%. (4) OD values should not be below historically established boundaries.

Results and discussion

In vitro

Results

Irritation / corrosion parameter:

% tissue viability

Run / experiment:

Single test with three tissues

Value:

102.6

Vehicle controls validity:

not applicable

Negative controls validity:

valid

Positive controls validity:

valid

Remarks on result:

no indication of irritation

Other effects / acceptance of results:

The acceptance criteria were met.

Any other information on results incl. tables

Results of the pre-experiment:

The optical pre-experiment (colour interference pre-experiment) to investigate the test item’s colour change potential in water did not lead to a change in colour. Therefore, an additional test with viable tissues (without MTT addition) was not necessary.

Optical evaluation of the MTT-reducing capacity of the test item after 1 hour incubation with MTT-reagent did not show blue colour. Therefore, an additional test with freeze-killed tissues was not necessary.

Results after treatment with the test item and the controls:

Dose Group	Exposure Interval	Tissue No.	Absorbance 570 nm Well 1	Absorbance 570 nm Well 2	Absorbance 570 nm Well 3	Mean Absorbance of 3 Wells	Mean- Absorba nce of three wells blank corrected	Mean Absorbance of 3 tissues after blank correction	Rel. Absorbance [%] Tissue 1, 2 + 3*	Relative Standard Deviation [%]	Mean Rel. Absorbance [% of Negative Control]**
Blank			0.038	0.039	0.039	0.038	0.000
Negative Control	60 min	Tissue 1	1.658	1.633	1.664	1.652	1.613	1.690	95.5	4.0	100.0
		Tissue 2	1.792	1.783	1.755	1.777	1.738		102.9
		Tissue 3	1.782	1.766	1.721	1.756	1.718		101.7
Positive Control	60 min	Tissue 1	0.104	0.100	0.101	0.101	0.063	0.060	3.7	5.3	3.5
		Tissue 2	0.094	0.096	0.096	0.095	0.057		3.4
		Tissue 3	0.097	0.098	0.097	0.097	0.059		3.5
Test Item	60 min	Tissue 1	1.806	1.764	1.730	1.767	1.728	1.734	102.3	4.1	102.6
		Tissue 2	1.912	1.813	1.810	1.845	1.807		106.9
		Tissue 3	1.720	1.700	1.693	1.704	1.666		98.6

* relative absorbance per tissue [rounded values]:100× (absorbance_tissue)/( mean absorbance_{negative control})

** relative absorbance per treatment group [rounded values]:100× (meanabsorbance_{test item/positive control})/( mean absorbance_{negative control})

The mean relative absorbance value of the test item, corresponding to the cell viability, did not decrease (102.6%; threshold for irritancy: ≤ 50%), consequently the test item was not irritant to skin.

Applicant's summary and conclusion

Interpretation of results:

other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No. 1272/2008

Conclusions:

In conclusion, it can be stated that in this study and under the experimental conditions reported, the test item is not irritant to skin according to UN GHS and EU CLP regulation.

Executive summary:

This in vitro study was performed to assess the irritation potential of the test substance by means of the Human Skin Model Test. The test was performed according to OECD 439 and GLP.

The test item did not reduce MTT (test for direct MTT reduction), and it did not change colour when mixed with deionised water (test for colour interference). Also its intrinsic colour was not intensive. Consequently, additional tests with freeze-killed or viable tissues were not necessary.

Each three tissues of the human skin model EpiDerm™ were treated with the test item, the negative or the positive control for 60 minutes.

30 μL of the test item were applied to each tissue, and spread to match the surface of the tissue. 30 μL of either the negative control (DPBS) or the positive control (5% SLS) were applied to each tissue. After treatment with the negative control the absorbance values were well within the required range of the acceptability criterion of mean OD≥0.8 and ≤ 2.8 for the 60 minutes treatment interval, thus assuring the quality of the tissues. Treatment with the positive control induced a sufficient decrease in the relative absorbance as compared to the negative control for the 60 minutes treatment interval, and thus assuring the validity of the test system.

After treatment with the test item, the mean relative absorbance value was 102.6% compared to the relative absorbance value of the negative control. This value is above the threshold for irritancy of ≤ 50%. Therefore, the test item is not considered to possess an irritant potential.

In conclusion, it can be stated that in this study and under the experimental conditions reported, the test substance is not irritant to skin.